feed,title,long_url,short_url
Benzinga,"Nicox Initiates Phase 2b Trial of NCX 4251, a Potential First-in-Class Treatment for Blepharitis",https://www.benzinga.com/pressreleases/20/12/g18788598/nicox-initiates-phase-2b-trial-of-ncx-4251-a-potential-first-in-class-treatment-for-blepharitis,https://j.mp/3r5eror
